Login
Toggle navigation
Videos
Categories
Trending
Christoph Vilanek, CEO of Freenet, discusses corporate culture and leadership in a video with viewer comments.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Christoph Vilanek, CEO of Freenet
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Revolutionizing Mining: Gecko's Low-Energy Processing and Innovative Collaboration on the Hope Bay Project
00:10:00
Jean Salata on Fueling Asia's Private Equity Growth Amid Pandemic Challenges and Future Investments | Jean Salata, CEO, Baring Private Equity Asia Ltd.
00:10:00
Invests in female-led companies working on the biggest areas|Nisha Dua,Managing Partner and Co-Founder,BBG Ventures
00:10:00
Why Understanding Military History is Crucial for Democracy
00:10:00
Navigating the Renewable Energy Landscape: Insights from a CEO's Perspective | João Manso Neto, CEO, Greenvolt Energias Renovaveis SA.
00:10:00
Stifel CEO Ron Kruszewski's Fed Rate Cut Forecast for the Year | Ronald J Kruszewski, CEO , Stifel Financial Corp.
00:10:00
CEO Alan Trefler positions Pegasystems Inc. strategically for long-term success in customer engagement.
00:10:00
Weston Goldmines' Growth and Innovations: From Exploration Success to Strategic Partnerships.
00:00:00
Chenghua Gu, PhD Professor of Neurobiology, HMS | Neural and Vascular Systems' Influence on the Brain
00:10:00
In Business time is one of the most important thing|Arjan Schütte,Founder and Managing Partner,Core Innovation Capital
00:10:00
BBVA's Successful Year: Growth, Profitability, and Societal Impact | Carlos Torres Vila , President , BBVA .
00:10:00
Understanding What Women Want in Finance: Key Insights